This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

5 Stocks Insiders Love Right Now

Gilead Sciences

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders are buying up a decent amount of stock in Gilead Sciences (GILD - Get Report), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets. Insiders are loading up into strength here since this stock is u over 23% so far in 2012.

Gilead Sciences has a market cap of $33.7 billion and an enterprise value of $31.9 billion. This stock trades at a cheap valuation, with a trailing price-to-earnings of 12.61 and a forward price-to-earnings of 10.27. Its estimated growth rate for this year is -1%, and for next year it's pegged at 14.1%. This is a cash-rich company, since the total cash position on its balance sheet is $9.96 billion and its total debt is $7.92 billion.

A director just bought 10,000 shares, or about $439,000 worth of stock, at $44 per share.

From a technical perspective, GILD is currently trading above its 200-day moving average and right below its 50-day moving average, which is neutral trendwise. This stock recently gapped down from over $54 to below $45 a share on monster volume. That huge gap down has done some technical damage on the chart that could take some time to fix.

If you're bullish on GILD, I would look for long-biased trades once this stock moves back above its 50-day moving average of $44.90 on high-volume. Look for volume on a move and close back above that level that's near of well above its three-month average action of 10,773,400 shares.

If we get that action soon, I would then add to any long positions once GILD trades above its gap down day high of $48 with volume. Look for some of that gap to get filled if $48 is taken out with volume. I would completely avoid any long biased traders in GILD if its recent low of $43.81 a share is taken out on high-volume.

Gilead shows up on a list of Health Care Stocks Bought and Sold by Hedge Funds in the most recent quarter.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ALNY $101.53 0.00%
CHRS $31.59 0.00%
GILD $103.53 0.00%
OPK $14.22 -4.20%
XL $36.20 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs